Skip to content

Low Creatinine Level and Respiratory Failure

A Correlation of Low Serum Creatinine Levels and Respiratory Function in the Mechanically Ventilated Patients in the Intensive Care Unit

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04368325
Enrollment
107
Registered
2020-04-29
Start date
2015-05-17
Completion date
2017-06-16
Last updated
2020-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intensive Care Unit, Muscle Weakness, Respiratory Insufficiency

Keywords

Low serume creatinine levels, respiratory insufficiency, ICU

Brief summary

Low creatinine levels may be a sign of muscle atrophy or weakness, and therefore predictive for respiratory insufficiency in the Intensive care unit (ICU) patients. The investigators compared the outcomes of participants with low creatinine levels with subsequent ICU participants admitted into ICU in the tertiary hospital.

Detailed description

The investigators have found a total of 46 participants with low creatinine levels and compared their outcome data with a group of participants with normal or high creatinine levels (control group, N=61). Low creatinine was defined as values of ≤40 μmol/L. Demographic data, type of admission (medical vs. surgical), hemoglobin values, CRP, and ventilator days were compared. A statistical analysis was performed using chi square and T-test.

Interventions

DIAGNOSTIC_TESTSerum creatinine levels

Comparison of treatment length using mechanical ventilaton, length of stay in ICU, survival between two groups

Sponsors

Josip Juraj Strossmayer University of Osijek
CollaboratorOTHER
Osijek University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria for study group was value of ≤40 µmol/L serume creatinine level during hospitalization in ICU from July 2015 to November 2016.

Exclusion criteria

* Patients who were younger than 18 years

Design outcomes

Primary

MeasureTime frameDescription
Length of mechanical ventilation treatment in group with low serume creatinine levelThrough study completion, an average of 1 yearThe investigators compared length of mechanical ventilation treatment between group with low serume creatinine level and control group

Secondary

MeasureTime frameDescription
White blood cell values in group with low creatinine levelThrough study completion, an average of 1 yearThe investigators compared white blood cell values between group with low creatinine level and control group
Hemoglobine values in group with low creatinine levelThrough study completion, an average of 1 yearThe investigators compared hemoglobine values between group with low creatinine level and control group
Number of patients who started nutrition in ICUThrough study completion, an average of 1 yearThe investigators compared number of patients between group with low creatinine level and control group who started nutrition in ICU
Length of stay in ICU in group with low serume creatinine levelThrough study completion, an average of 1 yearThe investigators compared length of stay in ICU between group with low serume creatinine level and control group
Number of patients who receive blood products transfusionThrough study completion, an average of 1 yearThe investigators compared number of patients who received blood products between group with low creatinine level and control group
Number of patients dischargedThrough study completion, an average of 1 yearThe investigators compared number of patients who were discharged from intensive care unit to the ward between group with low creatinine level and control group
Platelets values in group with low creatinine levelThrough study completion, an average of 1 yearThe investigators compared platelet values between group with low creatinine level and control group

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026